-
公开(公告)号：US20240363227A1
公开(公告)日：2024-10-31
申请号：US18645889
申请日：2024-04-25
申请人： REMEPY HEALTH LTD
发明人： Amir AMEDI , Michal TSUR-SHALEV , Or SHOVAL , Shahar SHELLY , Nira Neomi SAPORTA
摘要： The presently disclosed subject matter relates to the field of digital therapeutics to improve immune function. A primary mode of delivering the digital therapeutics is using sensory means comprising: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. The invention also provides combination therapies that comprise digital interventions together with non-digital interventions such as medicinal agents.
-
公开(公告)号：US20240363205A1
公开(公告)日：2024-10-31
申请号：US18612109
申请日：2024-03-21
申请人： SUPERSONIC IMAGINE
摘要： Examples of this disclosure relate to a system configured to determine a dynamic examination process, the system including a processing unit configured to determine a dynamic examination process based on a pathology hypothesis using a predefined algorithm, the dynamic examination process being associated with obtaining medical data, wherein the dynamic examination process is adaptable during its execution based on the obtained medical data.
-
公开(公告)号：US20240355445A1
公开(公告)日：2024-10-24
申请号：US18634608
申请日：2024-04-12
摘要： The invention relates generally to medication therapy and more particularly to a system and methods for medication therapy management to support improved adherence and alert clinicians of changes in behavior or symptoms. The system may facilitate interactions between various data sources (e.g., medical health records, genomics databases, and other connected third-party devices) to manage workflow, execute rules, interface with knowledge bases, codify information, schedule events, provide notification, and more. In addition, the system may include a conversational or actionable artificial intelligence persona tailored to each user and configured to, for example, converse, instruct, and/or coach a user according to one or more features of the system. Advantageously, the system may improve adherence and facilitate patient engagement, care transition, and disease management, resulting in, for example, reduced healthcare costs for providers and payers, and enhanced drug use for pharmaceutical manufacturers, pharmacies, and specialty pharmacies.
-
4.发明公开公开(公告)号：US20240347155A1
公开(公告)日：2024-10-17
申请号：US18439707
申请日：2024-02-12
发明人： Fredric L Coe , Brian J. Coe , John R. Asplin , Enno de Vries , Elaine Worcester
摘要： A method is provided, the method including receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form. A system including a processor is provided, a software adapted to be executed on said processor, said software comprising instructions for receiving a test result data, wherein said test result data represents a result of a test on a physical specimen, associating said test result data with a standard-of-care data, wherein said standard-of-care data represents a recommended course of action for the condition represented by the test result data, and transforming said specimen data and said standard-of-care data into a human-readable form.
-
公开(公告)号：US20240339184A1
公开(公告)日：2024-10-10
申请号：US18649504
申请日：2024-04-29
申请人： ProSciento, Inc.
发明人： Marcus Hompesch , Maria Nunez , Helge Guenther , Will Santos , Zoe Molina , Brian Mooney
摘要： A patient portal system may include a patient database module to interpret a patient profile value and a clinical database module to interpret a clinical study description. The patient database module may also interpret patient clinical data in response to the patient profile value and the clinical study description, and include at least a portion of the patient clinical data as longitudinal data of a patient corresponding to the patient profile value. The system may also include a patient interface module to implement a patient engagement interface and to interpret a patient medical event value in response to patient interactions with the patient engagement interface. The patient database may also adjust the longitudinal data in response to the patient medical event value.
-
公开(公告)号：US12112837B2
公开(公告)日：2024-10-08
申请号：US17364404
申请日：2021-06-30
申请人： Ilango Ramanujam
发明人： Ilango Ramanujam
摘要： A method and a clinical data standards (CDS) automated system are provided for automating clinical data standards and generating study data tabulation model (SDTM) artifacts required for a regulatory submission process using a machine learning model and a natural language processing (NLP) engine with minimal user intervention. The CDS automated system extracts metadata from multiple raw datasets automatically using NLP and feeds the extracted metadata into the machine learning model; predicts automatic case report form (CRF) annotations on the extracted metadata and records new learnings onto the CDS automated system; maps one or more raw datasets against a target SDTM variable; generates an SDTM statistical analysis system (SAS) code, an SDTM specification, and one or more SDTM datasets; generates a define package; validates the generated define package and the SDTM artifacts generated throughout the entire cycle; and generates validation reports in real time.
-
公开(公告)号：US20240321466A1
公开(公告)日：2024-09-26
申请号：US18578846
申请日：2022-07-14
申请人： KEVIN POTTIE , DANIEL LEGER
发明人： KEVIN POTTIE , DANIEL LEGER
摘要： Public misinterpretation of Internet health information represents a major liability in terms of both public inferences, health professional information processing, and costly. A system acquiring recommendations from “peer” level issuers of health and medical recommendations that provides portals allowing medical professionals to maintain their knowledge and the general public to acquire recommendations in plain language would help address these issues. Such a system would allow a medical professional to direct patients to this online source and track their usage it, allow medical certification authorities to track medical professional knowledge acquisition and establish time expiring ratings of current knowledge. The system ingests health recommendations and ensures they reach the public in the form of personalized plain language messages whilst allowing the local nature of inferences, influences, and knowledge, to factor into individual decision making through geographical clusters of knowledge.
-
公开(公告)号：US12100317B2
公开(公告)日：2024-09-24
申请号：US17132979
申请日：2020-12-23
摘要： Embodiments are disclosed herein for providing objective electronic medical record (EMR) system adoption analysis. In one embodiment subjective and objective inputs are received by a user via a user computing device. The subjective input includes at least one of knowledge of an EMR system, attitude towards the EMR system, or practice with the EMR system. The objective input includes demographic data related to the user of the EMR system. A score is then calculated for the objective and subjective input. Calculating the score includes weighting the objective and the subjective input to determine one or more of a knowledge score, an attitude score, or a practice score. It is determined that at least the attitude score is below a predetermined threshold. In response, an intervention module associated with attitude score is automatically transmitted to the user.
-
公开(公告)号：US20240312576A1
公开(公告)日：2024-09-19
申请号：US18673319
申请日：2024-05-24
申请人： FUJIFILM CORPORATION
发明人： Caihua WANG
IPC分类号： G16H10/20
CPC分类号： G16H10/20
摘要： A clinical trial support apparatus includes a processor, in which the processor predicts a progression speed of a target disease for subjects of a clinical trial, divides the subjects into a plurality of groups according to a prediction result of the progression speed of the target disease, and allocates the subjects to a treatment group to which a test drug is administered and a placebo group to which a placebo is administered for each of the plurality of groups.
-
公开(公告)号：US20240311387A1
公开(公告)日：2024-09-19
申请号：US18676436
申请日：2024-05-28
申请人： DRUGDEV INC.
IPC分类号： G06F16/248 , G06F16/2455 , G16H10/20 , G16H10/60
CPC分类号： G06F16/248 , G06F16/24553 , G16H10/20 , F04C2270/041 , G16H10/60
摘要： A computer-implemented method for sharing access to a database of records relating to clinical trial investigators amongst a number of users is disclosed. Each record includes a number of data fields associated with a clinical trial investigator and has associated metadata indicating a record owner. The method comprises: a) receiving a database query from a first user; b) resolving the query using a first subset of the records in the database including only those records for which the associated metadata indicates that the record owner is the first user and those records for which the associated metadata indicates that the record owner is another user which has registered a sharing rule in respect of the first user, whereby the first user is granted permission to access its records; and c) generating a result set including only those records used to resolve the query that satisfy the query.
-
-
-
-
-
-
-
-
-
搜索结果
2766 条记录 (耗时 0.032 秒)
